applic
capsaicin
solut
onto
rat
pharyng
mucosa
caus
wellreproduc
increas
vascular
permeabl
pharynx
capsaicininduc
pharyng
inflamm
unaffect
histamin
hi
blocker
nonsteroid
antiinflammatori
agent
wherea
dexamethason
effect
inhibit
dual
antagonist
tachykinin
nki
nkz
receptor
select
antagonist
nki
receptor
significantli
inhibit
capsaicininduc
plasma
exud
pharynx
capsaicin
anim
applic
capsaicin
solut
pharyng
mucosa
induc
pharyng
result
suggest
mechan
capsaicininduc
pharyng
primarili
involv
tachykinin
gen
pharmac
pharynx
alway
expos
variou
extern
stimuli
nasal
oral
caviti
pharyng
common
inflammatori
syndrom
oropharynx
attribut
predominantli
infecti
caus
less
commonli
secondari
involv
system
noninfecti
ill
complaint
pharyng
frequent
encount
respons
estim
million
outpati
visit
unit
state
vukmir
irrit
sore
throat
accompani
mild
edema
erythema
pharynx
present
patient
common
cold
syndrom
due
virus
rhinovirus
coronavirus
influenza
virus
parainfluenza
virus
adenovirus
bacteria
includ
streptococcu
pyogen
lang
singh
peter
howev
suitabl
anim
model
studi
pharyng
develop
effect
drug
hitherto
report
capsaicin
pungentalges
ingredi
red
pepper
activ
popul
primari
affer
sensori
neuron
caus
releas
neuropeptid
substanc
p
sp
neurokinin
nka
buck
burk
capsaicinsensit
nerv
recogn
distribut
varieti
tissu
includ
lower
respiratori
tract
buchan
adcock
nasal
mucosa
tani
et
al
capsaicin
use
induc
cough
anim
assess
antituss
drug
kamei
et
al
induc
bronchoconstrict
studi
cholinerg
axon
reflex
respiratori
tract
buchan
adcock
present
articl
new
anim
model
studi
pharyng
use
capsaicin
appli
onto
rat
pharyng
mucosa
effect
sever
drug
capsaicininduc
plasma
exud
pharynx
investig
correspond
address
receiv
septemb
revis
januari
accept
februari
male
wistar
rat
weigh
g
tokyo
laboratori
anim
co
japan
use
anim
anesthet
urethan
gkg
sc
place
supin
posit
given
spontan
respir
tracheal
cannula
experiment
pharyng
induc
applic
capsaicin
solut
moisten
cottontip
applic
surfac
pharyng
mucosa
capsaicin
solut
appli
tongu
slightli
pull
forcep
pharynx
area
open
deep
oral
caviti
small
rib
spreader
capsaicinsoak
cotton
swabe
sec
gentli
three
time
one
time
point
l
capsaicin
solut
left
mucosa
capsaicin
dissolv
mixtur
tween
distil
water
rat
control
group
given
vehicl
alon
capsaicin
concentr
mm
use
concentr
capsaicin
solut
appli
twice
interv
experi
capsaicin
solut
ram
appli
period
min
allow
evalu
plasma
exud
quantit
evalu
capsaicininduc
plasma
exud
rat
pharyng
mucosa
extravas
evan
blue
eb
dye
pharyng
tissu
determin
specif
eb
dye
mgkg
inject
iv
femor
vein
min
prior
first
applic
capsaicin
thirti
minut
experi
min
last
capsaicin
applic
exsanguin
done
abdomin
aorta
anim
head
portion
perfus
rate
mlmin
ml
citric
acid
buffer
paraformaldehyd
sodium
citrat
solut
adjust
ph
citric
acid
solut
via
bilater
carotid
arteri
expel
intravascular
dye
perfus
buffer
elimin
incis
right
atrium
bilater
musculu
masset
rat
incis
lower
jaw
remov
enabl
extirp
pharynx
pharynx
isol
separ
esophagu
trachea
remov
soft
palat
tongu
larynx
nasal
tissu
isol
pharynx
contain
portion
rang
caudal
end
soft
palat
epiglotti
begin
larynx
weigh
rag
eb
dye
tissu
extract
formamid
hr
determin
spectrophotometr
nm
tissu
dye
content
express
microgram
dye
per
gram
wet
weight
tissu
studi
involv
chemic
mediat
capsaicininduc
pharyng
plasma
exud
rat
inject
iv
sever
agent
femor
vein
rain
rain
case
dexamethason
glycyrrhizin
acid
prior
capsaicin
treatment
pretreat
drug
chlorpheniramin
mgkg
histamin
h
receptor
antagonist
indomethacin
mgkg
diclofenac
mgkg
cyclooxygenas
inhibitor
dexamethason
mgkg
steroid
antiinflammatori
drug
glycyrrhizin
acid
mgkg
mgkg
tachykinin
nki
receptor
antagonist
mgkg
tachykinin
receptor
antagonist
given
control
rat
receiv
vehicl
salin
instead
drug
experi
rat
pretreat
system
capsaicin
deplet
sensori
neuropeptid
capsaicin
done
use
method
yonei
et
al
minor
modif
anim
administ
subcutan
total
dose
mgkg
capsaicin
two
increas
dose
day
use
experi
day
last
system
capsaicin
pretreat
dose
made
follow
day
mgkg
day
mgkg
capsaicin
dissolv
tween
salin
counteract
respiratori
impair
caus
system
capsaicin
terbutalin
mgkg
sc
rain
prior
aminophyllin
mgkg
ip
min
prior
pretreat
capsaicin
treatment
anesthesia
ketamin
mgkg
sc
thiopent
sodium
mgkg
dosag
regimen
use
control
anim
deliv
equival
volum
vehicl
ethanol
tween
salin
without
capsaicin
check
effect
capsaicin
drop
solut
capsaicin
salin
instil
one
eye
rat
test
carri
hr
experi
untreat
vehiclepretr
rat
respond
instantli
wipe
eye
wherea
capsaicinpretr
rat
follow
drug
use
capsaicin
citric
acid
sodium
citrat
sodium
carbon
tween
dimethylsulfoxid
formamid
wako
pure
chemic
industri
osaka
japan
evan
blue
eb
merck
chlorpheniramin
maeat
indomethacin
diclofenac
sodium
urethan
sigma
dexamethason
dexamethason
sodium
phosphat
intraven
infus
banyu
pharmaci
co
glycyrrhizin
acid
glycyrrhizin
dipotassium
tokiwa
plant
chemistri
research
co
japan
fujisawa
pharmaceut
co
osaka
indomethacin
dissolv
salin
adjust
ph
sodium
carbon
dissolv
dimethylsulfoxid
dmso
drug
dissolv
andor
dilut
salin
data
express
mean
sem
statist
signific
determin
student
ttest
unpair
data
cochran
cox
test
oneway
analysi
varianc
anova
anova
carri
tukey
test
multipl
comparison
singl
doubl
applic
capsaicin
mm
surfac
pharyng
mucosa
attempt
shown
figur
increas
eb
exud
assess
rain
local
applic
capsaicin
eb
exud
pharynx
significantli
increas
min
singl
applic
group
b
min
doubl
applic
capsaicin
interv
group
c
p
vs
vehicl
fig
maxim
percentag
increas
eb
exud
observ
group
c
increas
percentag
versu
vehicl
control
concentr
capsaicin
mm
agent
gl
appli
surfac
pharynx
fig
capsaicin
elicit
concentrationdepend
increas
eb
extravas
rat
pharyng
tissu
increas
signific
mm
p
vs
vehicl
base
find
induct
pharyng
inflamm
perform
two
applic
interv
capsaicin
concentr
mm
subsequ
experi
influenc
variou
agent
enhanc
pharyng
plasma
exud
twice
applic
mm
capsaicin
summar
tabl
chlorpheniramin
mgkg
iv
histamin
hi
blocker
indomethacin
mgkg
iv
diclofenac
mgkg
iv
cyclooxygenas
inhibitor
glycyrrhizin
acid
mgkg
iv
triterpenoid
sapogenin
glycyrrhiza
glabra
l
possess
antiinflammatori
effect
finney
somer
without
effect
capsaicininduc
increas
eb
exud
contrast
dexamethason
mgkg
iv
steroid
antiinflammatori
drug
significantli
inhibit
increas
vascular
permeabl
induc
capsaicin
p
vs
control
mgkg
iv
tachykinin
nk
receptor
antagonist
significantli
inhibit
capsaicininduc
increas
eb
exud
dosedepend
manner
inhibit
respect
p
vs
vehicl
fig
mgkg
iv
tachykinin
nk
receptor
antagonist
also
significantli
inhibit
increas
plasma
exud
dose
mgkg
p
vs
vehicl
fig
deplet
sensori
neuropeptid
sp
nka
system
capsaicin
total
capsaicin
dose
mgkg
sc
perfoml
describ
materi
method
capsaicininduc
increas
eb
exud
significantli
attenu
system
capsaicin
p
vs
sham
treatment
group
fig
pharyng
inflammatori
syndrom
oropharynx
deriv
predominantli
infecti
caus
less
commonli
secondari
involv
system
noninfecti
ill
cigarett
smoke
also
sometim
caus
sore
throat
pathogenesi
infecti
pharyng
infect
virus
rhinoviru
coronaviru
adenoviru
bacteria
streptococcu
pyrogen
chlamydia
trachomati
mycoplasma
pneumonia
haemophilu
influenza
virul
streptococcu
infect
exampl
depend
local
invas
cellular
enzym
streptokinas
hyaluronidas
vukmir
preliminari
studi
attempt
applic
capsaicin
alon
hyaluronidas
uml
plu
capsaicin
pharyng
mucosa
rat
result
signific
differ
induc
pharyng
exud
observ
group
therefor
use
capsaicin
alon
lo
figur
concentrationrel
eff
capsaicin
mm
evan
blue
eb
exudht
rat
pharynx
capsaicin
appli
twice
interv
rat
pharyng
mucosa
column
repres
mean
se
six
seven
anim
p
vs
vehicl
control
present
studi
induc
experiment
pharyng
experiment
pharyng
laboratori
anim
report
far
know
oropharynx
consist
mucos
membran
layer
stratifi
squamou
epithelium
protect
mucosa
physic
chemic
thermal
stimuli
given
food
drink
inspir
air
robust
oropharyng
mucosa
may
reason
good
model
pharyng
avail
far
capsaicin
known
prototyp
neurogen
irrit
topic
applic
capsaicin
rat
skin
lead
excit
affer
neuron
kenin
increas
skin
blood
flow
inou
et
al
vasodil
lynn
et
al
neuropeptid
sp
nka
releas
capsaicin
peripher
end
affer
neuron
consid
chemic
mediat
skin
inflamm
holzer
holzer
maggi
meli
saria
et
al
sp
tachykinin
found
cfiber
nerv
end
airway
varieti
speci
includ
human
influenc
sever
airway
function
increas
mucu
secret
epitheli
chlorid
secret
vascular
permeabl
stimul
airway
smooth
muscl
contract
martl
present
experi
mm
capsaicin
increas
vascular
permeabl
rat
pharynx
reach
signific
effect
min
report
ear
edema
develop
rapidli
reach
maximum
rain
topic
capsaicin
applic
surfac
mous
ear
fxgear
capsaicin
gabor
razga
inou
et
al
experi
concentrationdepend
enhanc
plasma
exu
dation
observ
increas
concentr
capsaicin
mm
calcul
amount
capsaicin
appli
onto
drug
test
administ
intraven
rain
chlorphenirarnin
indomethacin
diclofenac
min
dexamethason
glycyrrhizin
acid
prior
first
capsaicin
applic
surfac
pharyng
mucosa
valu
repres
mean
se
five
seven
anim
p
vs
control
pharyng
mucosa
bgpharynx
pa
mm
capsaicin
solut
respect
therefor
effect
dose
need
increas
plasma
exud
pharynx
seem
lower
ear
reason
might
due
differ
capsaicin
absorpt
applic
site
mucosa
outer
skin
andor
speci
differ
antihistamin
chlorpheniramin
neglig
effect
capsaicininduc
rat
pharyng
plasma
exud
dose
chlorpheniramin
mgkg
iv
use
present
dose
suffici
inhibit
bronchoconstrict
induc
histamin
inhal
dog
yamatak
et
al
report
neuropeptid
liber
capsaicin
activ
sensori
nerv
abl
releas
histamin
mast
cell
gabor
razga
inou
et
al
wang
et
al
howev
present
studi
may
case
result
might
consist
result
studi
vivo
experi
concern
trachea
esophagu
conjunctiva
paw
skin
urinari
bladder
nasal
mucosa
lower
respiratori
tract
rat
group
report
enough
high
local
sp
concentr
necessari
activ
mast
cell
sp
lower
concentr
act
mainli
via
mechan
wherebi
mast
cell
involv
cyclooxygenas
inhibitor
indomethacin
diclofenac
effect
capsaicininduc
pharyng
plasma
exud
dose
indomethacin
mgkg
iv
complet
block
decreas
arteri
blood
pressur
produc
iv
inject
mg
arachidon
acid
dog
robert
et
al
also
often
use
typic
dose
complet
blockad
cyclooxygenas
vivo
experi
hong
et
al
kuroiwa
et
al
yoshihara
et
al
yoshihara
et
al
iv
administr
diclofenac
sodium
mgkg
prevent
eb
leakag
induc
electr
stimul
rat
dental
pulp
kerezoudi
et
al
addit
preadminist
diclofenac
mgkg
iv
inhibit
carrageenaninduc
inflamm
rat
ankl
paw
buritova
et
al
diclofenac
dose
mgkg
iv
seem
suffici
antiinflammatori
effect
although
present
without
effect
present
result
cyclooxygenas
inhibitor
conceiv
role
prostaglandin
would
minim
pharyng
model
accord
result
inou
et
al
indomethacin
mgkg
oral
aspirin
mgkg
oral
suppress
capsaicininduc
mous
ear
edema
suggest
prostaglandin
primarili
mediat
develop
capsaicininduc
ear
edema
furthermor
wang
et
al
report
pretreat
indomethacin
mgkg
ip
effect
spinduc
ear
edema
mice
also
glycyrrhizin
acid
mgkg
iv
reduc
rat
pharyng
plasma
exud
induc
capsaicin
iv
dose
glycyrrhizin
acid
inhibit
passiv
anaphylaxi
reaction
rat
conjunctiva
iso
et
al
glycyrrhizin
report
similar
action
steroid
antiinflammatori
drag
although
effect
much
weaker
steroid
finney
somer
hand
steroid
antiinflammatori
agent
dexamethason
mgkg
iv
effect
suppress
capsaicininduc
increas
plasma
exud
present
studi
inou
et
al
appli
capsaicin
mous
ear
caus
edema
dexamethason
mgkg
appli
topic
greatli
effect
inhibit
sheppard
et
al
report
dexamethason
dose
mgkg
iv
significantli
reduc
edema
laser
exposur
rat
skin
mechan
antiexud
action
steroid
pharyng
mucosa
unexplain
could
possibl
due
phospholipas
inhibit
lead
inhibit
gener
product
inhibit
gener
cyclooxygenas
product
indomethacin
diclofenac
without
effect
model
effect
dosedepend
suppress
capsaicininduc
increas
pharyng
plasma
exud
dual
antagonist
nki
receptor
select
antagonist
receptor
sensori
neuropeptid
sp
nka
consid
involv
pharyng
model
known
capsaicin
stimul
sensori
cfiber
caus
releas
sp
nka
nerv
end
ingenito
et
al
szallasi
et
al
neurogen
plasma
exud
induc
capsaicin
mediat
via
tachykinin
releas
capsaicinsensit
sensori
nerv
lundberg
saria
mural
et
al
edema
result
increas
microvascular
permeabl
vasodil
airway
guinea
pig
reportedli
induc
sp
potent
nka
murai
et
al
roger
et
al
suggest
nki
receptor
import
receptor
airway
edema
induc
sp
nka
capsaicin
present
experi
howev
inhibitori
action
seem
stronger
neurogen
plasma
protein
exud
rat
paw
induc
mustard
oil
sp
antidrom
stimul
saphen
nerv
vagal
stimul
inhibit
nki
receptor
antagonist
although
complet
lembeck
et
al
capsaicininduc
plasma
exud
guinea
pig
bronchi
also
inhibit
partli
complet
lei
et
al
therefor
like
capsaicininduc
pharyng
plasma
exud
present
studi
involv
nki
receptor
antagonist
receptor
similar
potenc
addit
possibl
rel
weak
effect
present
studi
due
exist
speci
differ
potenc
inhibit
sp
bind
guinea
pig
lung
membran
approxim
higher
affin
rat
brain
cortic
membran
fujii
although
anoth
nkj
antagonist
report
potent
inhibitor
sp
bind
rat
brain
membran
prepar
k
nm
nevertheless
effect
spinduc
guinea
pig
ileum
contract
rel
weak
garret
et
al
therefor
rel
weaker
effect
rat
tissu
might
deriv
characterist
probabl
characterist
nki
ceptor
rat
tissu
particip
subtyp
neurokinin
receptor
rat
pharyng
induc
capsaicin
necessari
clearli
demonstr
futur
present
rat
pharyng
model
first
one
capabl
quantit
determin
induc
pharyng
inflamm
requir
simpl
techniqu
provid
wellreproduc
result
howev
throat
inflamm
common
cold
syndrom
somewhat
treat
clinic
nonsteroid
antiinflammatori
drug
without
effect
studi
present
model
requir
improv
wish
thank
dr
yoshihiko
chiba
ms
tomoko
ishikawa
mr
masatoshi
ichiba
help
discuss
